Thu, Mar 5, 2015, 7:38 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Metabolix, Inc. Message Board

  • ledup111 ledup111 Feb 15, 2013 9:36 AM Flag



    Metabolix (MBLX) is a bioscience company that develops and is in the process of commercializing environmentally sustainable, economically attractive alternatives to petroleum-based plastics, with work underway to do the same with chemicals and energy. This stock is trading up 11.8% to $1.88 in recent trading.

    Today’s Range: $1.67-$1.85

    52-Week Range: $1.07-$3.48

    Volume: 115,000

    Three-Month Average Volume: 197,432

    From a technical perspective, MBLX is ripping higher here back above its 200-day moving average of $1.72 with decent volume. This move has also pushed shares of MBLX into breakout territory, since the stock has taken out some near-term overhead resistance at $1.78. Shares of MBLX are now quickly moving within range of triggering another major breakout trade. That trade will hit if MBLX manages to take out some near-term overhead resistance levels at $2 to $2.10 and then $2.19 with high volume.

    Traders should now look for long-biased trades in MBLX as long as it’s trending above its 200-day at $1.72, and then once it sustains a move or close above those breakout levels with volume that hits near or above 197,432 shares. If that breakout triggers soon, then MBLX will set up to re-test or possibly take out its next major overhead resistance levels at $2.32 to $2.67. Any high-volume move above $2.67 will then put $3 to $3.20 into range for shares of MBLX.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.8615-0.1085(-11.19%)Mar 5 3:58 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orexigen Therapeutics, Inc.
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orbital ATK, Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST